CYTODYN INC Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 10 of 10 Posts
E The Dream Team Disruptors - Einstein's In Biopharma 2020-2021
Article By: James Gornick Tuesday, November 24, 2020 7:18 AM EST
The trends in the final months of 2020 and moving into 2021 have assembled "The Dream-Team" in saving many lives and the losses in functionalities in those infected with COVID-19 World-Wide Pandemic.
In this article: AZN, JNJ, PFE, CYDY, ABIO, REGN, SPPI, MRNA, AXDX, CAPR, MESO, NVS Also: INO, SRNE, NVAX, DVAX, CRSP
Read
E Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
Article By: Moon Kil Woong Tuesday, November 10, 2020 5:47 PM EST
The corporate culture of CytoDyn Inc. has created an atmosphere where management is now able to realize the full potential of a drug that was essentially tossed in the garbage heap.
In this article: CYDY Also: GILD, LLY, REGN
Read
E CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
Article By: Moon Kil Woong Tuesday, October 20, 2020 2:35 PM EST
Cytodyn investors are not reacting positively to good news despite being extremely positive.
In this article: CYDY
Read
E CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Article By: Moon Kil Woong Friday, September 18, 2020 12:10 PM EST
This is to clarify the recent conference call and counter misleading information on it by shorters etc.
In this article: CYDY Also: IMMU, GILD
Read
E CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Article By: Moon Kil Woong Monday, August 3, 2020 8:00 PM EST
Cytodyn, is set to move on positive information and this article gives updated information on why it may move in the near term and an update on their Covid drug trial.
In this article: CYDY Also: GILD, ICPT
Read
CytoDyn Files Application With Nasdaq For Uplist
Article By: TalkMarkets Newswire Wednesday, July 15, 2020 5:53 PM EST
CytoDyn Inc., announced today it recently filed a comprehensive listing application package with The Nasdaq Stock Market to request an uplisting of the Company’s common stock.
In this article: CYDY
Read
E HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Article By: Moon Kil Woong Friday, July 3, 2020 11:10 AM EST
CytoDyn believes they have a cure for HIV that will work on a subpopulation of patients with cancer.
In this article: CYDY, GILD Also: MRK
Read
CytoDyn And Samsung BioLogics Enter Into Agreement To Manufacture $1 Billion Worth Of Leronlimab (PRO 140) To Meet Expected Demand For Future Revenues Post-Approval
Article By: TalkMarkets Newswire Tuesday, April 2, 2019 5:00 AM EST
CytoDyn, a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced the execution of a comprehensive strategic agreement with Samsung BioLogics.
In this article: CYDY
Read
5 Best Biotech Stocks To Buy In October
Article By: Zacks Investment Research Monday, October 1, 2018 11:50 AM EST
Here are five stocks that are expected to move north following successful drug developments.
In this article: CSBR, CYDY, INFI, NKTR, ZTS Also: AMRN, ACAD, SRPT, GILD, AGN
Read
Market Wrap February 03, 2016
Video By: Robert Desmond Thursday, February 4, 2016 5:18 AM EST
A review of last week's performance, plus a summary of the best stock charts for the coming week and where I think the markets are headed. (Video Length: 00:26:28)
In this video: UUP, GLD, UWTI, CYDY, XLF, LION, TVIX, SPXS, NTAP, UTG, COMP, FB, SPX, IXC, NUGT, PRO
Watch
1 to 10 of 10 Posts